TerSera Therapeutics LLC
5 clinical trials · Sponsor
◉ Watch TerSera Therapeutics LLC
| Record | Firm | Date |
|---|---|---|
| A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer (NCT07310420) | TerSera Therapeutics LLC | 2026-08-30 |
| Phase 2 Study IV QUZYTTIR™ (Cetirizine Hydrochloride Injection) vs V Diphenhydramine (NCT04189588) | TerSera Therapeutics LLC | 2020-03-25 |
| A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer (NCT03790111) | TerSera Therapeutics LLC | 2019-03-13 |
Track TerSera Therapeutics LLC automatically
Every clearance here is in the API, with alerts when new ones post.